Get startedLog in
    Picture of Ryvu Therapeutics SA logo

    RVU — Ryvu Therapeutics SA News Story

    0.000.00%
    pl flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapMomentum Trap
    All News

    Brief: Ryvu Therapeutics Clinical and Translational Data Is Accepted For Presentation in US

    Picture of Ryvu Therapeutics SA logoRyvu Therapeutics SA
    04/11/2021 14:36
    Nov 4 (Reuters) - Ryvu Therapeutics SA  RVU.WA :
    * ANNOUNCES THAT 5 ABSTRACTS DEMONSTRATING CLINICAL AND
PRECLINICAL ACTIVITY OF SELECTIVE CDK8/19 INHIBITOR RVU120
SEL120) AND SELECTIVE PIM/FLT3 INHIBITOR SEL24 (MEN1703) ARE
ACCEPTED FOR PRESENTATION
    * PRESENTATION TO BE HELD ON DEC 11 - DEC 14 IN ATLANTA
(USA) AT
63RD AMERICAN SOCIETY OF HEMATOLOGY (ASH) ANNUAL MEETING &
EXPOSITION

Source text for Eikon:  ID:nEM3SQ7hJa 
Further company coverage:  RVU.WA 

 (Reporting by Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;))

    Recent news on Ryvu Therapeutics SA

    See all news